BlackRock
FBIO icon

BlackRock’s Fortress Biotech FBIO Stock Holding History

BlackRock’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$550K Sell
197,085
-3,478
-2% -$11.8K ﹤0.01% 4505
2025
Q4 		$734K Buy
200,563
+10,769
+6% +$30.7K ﹤0.01% 4391
2025
Q3 		$701K Buy
189,794
+57,708
+44% +$146K ﹤0.01% 4389
2025
Q2 		$246K Buy
132,086
+16,298
+14% +$28.2K ﹤0.01% 4615
2025
Q1 		$181K Sell
115,788
-792
-0.7% -$1.4K ﹤0.01% 4630
2024
Q4 		$236K Buy
116,580
+5,552
+5% +$10.1K ﹤0.01% 4589
2024
Q3 		$160K Buy
111,028
+1,071
+1% +$2.04K ﹤0.01% 4573
2024
Q2 		$188K Buy
109,957
+35,018
+47% +$63.5K ﹤0.01% 4562
2024
Q1 		$150K Hold
74,939
– – ﹤0.01% 4647
2023
Q4 		$226K Sell
74,939
-2
-0% -$5 ﹤0.01% 4608
2023
Q3 		$326K Sell
74,941
-6,822
-8% -$46.8K ﹤0.01% 4546
2023
Q2 		$675K Sell
81,763
-11,877
-13% -$117K ﹤0.01% 4400
2023
Q1 		$1.15M Sell
93,640
-256
-0.3% -$3.05K ﹤0.01% 4288
2022
Q4 		$923K Buy
93,896
+57
+0.1% +$631 ﹤0.01% 4428
2022
Q3 		$1.21M Sell
93,839
-550
-0.6% -$8.24K ﹤0.01% 4408
2022
Q2 		$1.19M Sell
94,389
-220,103
-70% -$3.26M ﹤0.01% 4469
2022
Q1 		$6.42M Sell
314,492
-3,792
-1% -$104K ﹤0.01% 3821
2021
Q4 		$11.9M Buy
318,284
+7,727
+2% +$345K ﹤0.01% 3570
2021
Q3 		$15M Sell
310,557
-589
-0.2% -$28.8K ﹤0.01% 3472
2021
Q2 		$16.7M Sell
311,146
-12,612
-4% -$761K ﹤0.01% 3413
2021
Q1 		$17.1M Buy
323,758
+9,139
+3% +$516K ﹤0.01% 3261
2020
Q4 		$15M Buy
314,619
+10,677
+4% +$462K ﹤0.01% 3163
2020
Q3 		$18.4M Buy
303,942
+37,861
+14% +$1.93M ﹤0.01% 2896
2020
Q2 		$10.7M Buy
266,081
+230,154
+641% +$8.55M ﹤0.01% 3144
2020
Q1 		$1.02M Sell
35,927
-88
-0.2% -$2.92K ﹤0.01% 3864
2019
Q4 		$1.39M Buy
36,015
+7,598
+27% +$195K ﹤0.01% 3900
2019
Q3 		$601K Sell
28,417
-135
-0.5% -$3.17K ﹤0.01% 4122
2019
Q2 		$643K Sell
28,552
-94,830
-77% -$2.44M ﹤0.01% 4134
2019
Q1 		$3.29M Sell
123,382
-2,145
-2% -$56.2K ﹤0.01% 3552
2018
Q4 		$1.62M Sell
125,527
-1,009
-0.8% -$16.8K ﹤0.01% 3746
2018
Q3 		$3.04M Sell
126,536
-333
-0.3% -$10.7K ﹤0.01% 3641
2018
Q2 		$5.67M Buy
126,869
+7,819
+7% +$440K ﹤0.01% 3467
2018
Q1 		$8.13M Sell
119,050
-126
-0.1% -$7.98K ﹤0.01% 3221
2017
Q4 		$7.13M Buy
119,176
+1,225
+1% +$72.2K ﹤0.01% 3305
2017
Q3 		$7.82M Buy
117,951
+5,858
+5% +$395K ﹤0.01% 3307
2017
Q2 		$7.99M Buy
112,093
+6,521
+6% +$385K ﹤0.01% 3290
2017
Q1 		$5.86M Buy
105,572
+105,497
+140,663% +$4.72M ﹤0.01% 3338
2016
Q4 		$3K Hold
75
– – ﹤0.01% 3578
2016
Q3 		$3K Hold
75
– – ﹤0.01% 3552
2016
Q2 		$3K Buy
+75
New +$3.49K ﹤0.01% 3574
2013
Q4 		– Sell
-56
Closed -$6K – 3130
2013
Q3 		$6K Buy
56
+14
+33% +$1.72K ﹤0.01% 2917
2013
Q2 		$5K Buy
+42
New +$6.19K ﹤0.01% 3027

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock's FBIO Position: Q1 2026 in Review

BlackRock reduced its Fortress Biotech (FBIO) stake by 1.7% in Q1 2026, selling an estimated $11.8K and leaving 197,085 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #4505.

BlackRock first reported a position in FBIO in Q2 2013 and has held it in 42 quarters since. The position peaked at $18.4M in Q3 2020. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • BlackRock held 197,085 shares of Fortress Biotech worth $550K as of Q1 2026.
  • BlackRock sold 3,478 Fortress Biotech shares in Q1 2026, an estimated $11.8K.
  • Fortress Biotech made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4505 holding.
  • BlackRock first reported a position in Fortress Biotech in Q2 2013 and has held it in 42 quarters since.
  • BlackRock's Fortress Biotech position peaked at $18.4M in Q3 2020.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.